共 50 条
- [2] Re: Bimal Bhindi, Jeffrey Graham, J. Connor Wells, et al. Deferred Cytoreductive Nephrectomy in Patients with Newly Diagnosed Metastatic Renal Cell Carcinoma. Eur Urol. In press. https://doi.org/10.1016/j. eururo.2020.04.038 Cytoreductive Nephrectomy: To Whom and When? [J]. EUROPEAN UROLOGY ONCOLOGY, 2020, 3 (04): : 559 - 560
- [6] Re: Michael Baboudjian, Romain Diamand, Alessandro Uleri, et al. Does Overgrading on Targeted Biopsy of Magnetic Resonance Imaging-visible Lesions in Prostate Cancer Lead to Overtreatment? Eur Urol. In press. https://doi.org/10.1016/j.eururo.2024.02.003 [J]. EUROPEAN UROLOGY, 2024, 86 (03) : e71 - e71
- [7] Re: R. Jeffrey Karnes, Voleak Choeurng, Ashley E. Ross, et al. Validation of a Genomic Risk Classifier to Predict Prostate Cancer-specific Mortality in Men with Adverse Pathologic Features. Eur Urol. In press. https://doi.org/10.1016/j.eururo. 2017.03.036 [J]. EUROPEAN UROLOGY, 2017, 72 (06) : E157 - E157
- [9] Reply to Mattias Hoglund's Letter to the Editor re: Alexander Cox, Niklas Klumper, Johannes Stein, et al. Molecular Urothelial Tumor Cell Subtypes Remain Stable During Metastatic Evolution. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.03.020 [J]. EUROPEAN UROLOGY, 2023, 84 (02) : E51 - E52